Category — R&D
Another Attack on Pharma Seeding Trials
July 29, 2011 - Big Pharma is yet again under fire in a new article published in the Archives of Internal Medicine. Samuel D. Krumholz, David S. Egilman, & Joseph S. Ross, Study of Neurontin: Titrate to Effect, Profile of Safety (STEPS) Trial: A Narrative Account of a Gabapentin Seeding Trial, Arch Intern Med., vol. 171, no. 12, 1100-1107 (2011). This time, the topic of “seeding trials” is at issue. [Read more →]
July 29, 2011 Comments Off
